Home > Industry > Pharma DTC

Industry 03 · High Fit · Regulated

Pharma DTC

The pressure you're under:

Your media plan has to satisfy MLR review, FDA fair-balance requirements, brand-safety standards your legal team can defend, and a CFO who wants to see incremental script lift — not just impressions. Most agencies don't understand the regulatory layer, and the ones that do are charging you a premium for the privilege of compliance theater. Meanwhile, 58% of pharma marketers plan to increase CTV spend in 2026, and your team is being asked to scale into a channel without a partner who can navigate it cleanly.

Where CTV solves it:

CTV gives DTC pharma the brand-safe, premium-environment, household-precision targeting that linear can't and that social media won't risk. We work inside MLR-reviewed creative workflows, run HIPAA-aware audience targeting where the data partner allows, and stay inside premium streaming inventory — never on long-tail or open-exchange placements that introduce brand-safety exposure. Reporting is structured for compliance review, not just media review.

The KPIs we'll be accountable to:

Cost per branded search

Cost per HCP locator visit

Incremental Rx lift in test markets vs. holdout

Reach against verified in-market patient audiences

Brand favorability lift in adjacency-controlled studies

Built for the pharma DTC CMO whose media plan has to clear MLR, satisfy the CFO, and grow scripts in the same quarter — without inviting a brand-safety incident.